LILRB1 and precursor B-cell acute lymphoblastic leukemia: To assess the in vivo efficacy of the LILRB1 CAR, we utilized NOD scid gamma (NSG) mice implanted with RS4;11 B-ALL cells expressing GFP-luciferase (GFP-luc+) (Fig. 7A).